Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model

被引:1
作者
Li, Yi-Fan [1 ,2 ]
Yao, Lan-Qing [1 ]
Li, Chao [1 ]
Ren, Hong [3 ]
Gong, Jin-Bo [2 ]
Wu, Han [1 ]
Gu, Li-Hui [1 ]
Liang, Ying-Jian [4 ]
Yang, Yu-Ze [5 ]
Lin, Kong-Ying [6 ]
Li, Zi-Qiang [7 ,8 ]
Zheng, Qi-Xuan [9 ]
Chen, Ting-Hao [10 ]
Zhou, Ya-Hao [11 ]
Wang, Hong [12 ]
Guo, Hong-Wei [13 ]
Xu, Jia-Hao [1 ]
Chen, Zhong [2 ]
Shen, Feng [1 ]
Wang, Ming-Da [1 ]
Yang, Tian [1 ]
机构
[1] Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China
[2] Nantong Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Nantong, Peoples R China
[3] Shanghai Municipal Ctr Dis Control & Prevent, Dept Viral Hepatitis Control & Prevent, Shanghai, Peoples R China
[4] Harbin Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Harbin, Peoples R China
[5] First Hosp Jilin Univ, Gen Surg Ctr, Dept Hepatobiliary & Pancreat Surg, Changchun, Peoples R China
[6] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Hepatobiliary Surg, Fuzhou, Fujian, Peoples R China
[7] Shandong First Med Univ, Dept Liver Transplantat & Hepat Surg, Affiliated Hosp 1, Jinan, Peoples R China
[8] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
[9] Shandong First Med Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, Jinan, Shandong, Peoples R China
[10] Ziyang First Peoples Hosp, Dept Gen Surg, Ziyang, Peoples R China
[11] Puer Peoples Hosp, Dept Hepatobiliary Surg, Puer, Peoples R China
[12] Liuyang Peoples Hosp, Dept Gen Surg, Liuyang, Peoples R China
[13] Second Peoples Hosp Changzhi, Dept Gen Surg 2, Changzhi, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Hepatitis B virus; Hepatocellular carcinoma; Statistical cure; Risk stratification; Hepatectomy; Disease-free survival; Prognostic model; Reference populations; LIVER RESECTION;
D O I
10.1245/s10434-025-17176-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundStatistical cure, defined as achieving life expectancy comparable with that of disease-free individuals, has not been specifically investigated in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC), which accounts for more than 50% of the global HCC burden. This study aimed to develop a cure model for HBV-HCC after hepatectomy using matched HBV carriers and the general population as reference groups.MethodsFrom a Chinese multicenter database, HBV-HCC patients who underwent curative-intent hepatectomy were retrospectively reviewed. Independent prognostic factors were identified through Cox regression. A spline-based cure model was applied using two reference populations: matched Chinese HBV carriers (from Shanghai Center for Disease Control and Prevention) and the general population (from the National Bureau of Statistics).ResultsThe study analyzed 740 HBV-HCC patients. The following eight independent risk factors were identified: preoperative high viral load (hazard ratio [HR] 1.27), Child-Pugh grade (HR 1.21 and 1.43), multiple tumors (HR 1.70), tumor size greater than 5.0 cm (HR 1.47), macrovascular invasion (HR 3.33), microvascular invasion (HR 1.25), intraoperative blood transfusion (HR 1.21), and postoperative HBV reactivation (HR 1.89). The overall cure probability was 21.2% versus that for HBV carriers and 11.1% versus that for the general population. Risk stratification identified distinct groups relative to HBV carriers. Low risk (64.2%) showed an initial cure rate of 30.3% and achieved a 95% cure probability by 8.6 years, whereas high risk (10.5%) showed negligible cure probability.ConclusionsThis first HBV-HCC-specific cure model demonstrated that statistical cure is achievable for a subset of patients after hepatectomy. Risk stratification identifies patients with varying cure probabilities, providing valuable guidance for personalized treatment strategies and surveillance protocols.
引用
收藏
页码:4396 / 4407
页数:12
相关论文
共 55 条
[1]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[2]   Management of Hepatocellular Carcinoma A Review [J].
Brown, Zachary J. ;
Tsilimigras, Diamantis I. ;
Ruff, Samantha M. ;
Mohseni, Alireza ;
Kamel, Ihab R. ;
Cloyd, Jordan M. ;
Pawlik, Timothy M. .
JAMA SURGERY, 2023, 158 (04) :410-420
[3]   Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection [J].
Bullement, Ash ;
Willis, Anna ;
Amin, Amerah ;
Schlichting, Michael ;
Hatswell, Anthony James ;
Bharmal, Murtuza .
BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
[4]  
Chen X, 2021, AGING-US, V13, P22256, DOI 10.18632/aging.203531
[5]   Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients [J].
Crippa, Stefano ;
Malleo, Giuseppe ;
Langella, Serena ;
Ricci, Claudio ;
Casciani, Fabio ;
Belfiori, Giulio ;
Galati, Sara ;
Ingaldi, Carlo ;
Lionetto, Gabriella ;
Ferrero, Alessandro ;
Casadei, Riccardo ;
Ercolani, Giorgio ;
Salvia, Roberto ;
Falconi, Massimo ;
Cucchetti, Alessandro .
ANNALS OF SURGERY, 2024, 280 (06) :999-1005
[6]   The chances of hepatic resection curing hepatocellular carcinoma [J].
Cucchetti, Alessandro ;
Zhong, Jianhong ;
Berhane, Sarah ;
Toyoda, Hidenori ;
Shi, KeQing ;
Tada, Toshifumi ;
Chong, Charing C. N. ;
Xiang, Bang-De ;
Li, Le-Qun ;
Lai, Paul B. S. ;
Ercolani, Giorgio ;
Mazzaferro, Vincenzo ;
Kudo, Masatoshi ;
Cescon, Matteo ;
Pinna, Antonio Daniele ;
Kumada, Takashi ;
Johnson, Philip J. .
JOURNAL OF HEPATOLOGY, 2020, 72 (04) :711-717
[7]   A New Mixture Model With Cure Rate Applied to Breast Cancer Data [J].
Gallardo, Diego I. ;
Brandao, Marcia ;
Leao, Jeremias ;
Bourguignon, Marcelo ;
Calsavara, Vinicius .
BIOMETRICAL JOURNAL, 2024, 66 (06)
[8]   Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis [J].
Guerrini, Gian Piero ;
Esposito, Giuseppe ;
Olivieri, Tiziana ;
Magistri, Paolo ;
Ballarin, Roberto ;
Di Sandro, Stefano ;
Di Benedetto, Fabrizio .
CANCERS, 2022, 14 (14)
[9]   Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects [J].
Guo, Bin ;
Chen, Qian ;
Liu, Zhicheng ;
Chen, Xiaoping ;
Zhu, Peng .
FRONTIERS IN ONCOLOGY, 2023, 13
[10]   Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis [J].
He, Min-Ke ;
Peng, Chuan ;
Zhao, Yang ;
Liang, Run-Bin ;
Lai, Zhi-Cheng ;
Kan, Anna ;
Li, Qi-Jiong ;
Wei, Wei ;
Zhang, Yao-Jun ;
Chen, Min-Shan ;
Guo, Rong-Ping ;
Shi, Ming .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) :3207-3216